Cargando…
Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study
OBJECTIVES: The dosing interval of a primary vaccination series can significantly impact on vaccine immunogenicity and efficacy. The current study compared 3 dosing intervals for the primary vaccination series of the BNT162b2 mRNA COVID-19 vaccine, on humoral immune response and durability against S...
Autores principales: | Leong, Darryl P., Zhang, Ali, Breznik, Jessica A., Clare, Rumi, Huynh, Angela, Mushtaha, Maha, Rangarajan, Sumathy, Stacey, Hannah, Kim, Paul Y., Loeb, Mark, Denburg, Judah A., Mertz, Dominik, Chagla, Zain, Nazy, Ishac, Miller, Matthew S., Bowdish, Dawn M. E., Duong, MyLinh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931154/ https://www.ncbi.nlm.nih.gov/pubmed/36791069 http://dx.doi.org/10.1371/journal.pone.0281673 |
Ejemplares similares
-
Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents
por: Breznik, Jessica A., et al.
Publicado: (2021) -
Antibody Responses to Third-Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
por: Zhang, Ali, et al.
Publicado: (2022) -
Lessons from vaccine-induced immune thrombotic thrombocytopenia
por: Kelton, John Greenhow, et al.
Publicado: (2021) -
BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021) -
Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)